Position Statement Developed for Managing Blood Cancers in Pregnancy

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 8, 2025.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Jan. 8, 2025 -- In a new position statement published online Jan. 3 in The Lancet Haematology, guidelines are presented for the management of acute leukemia and aggressive lymphomas in pregnancy.

Georgia Mills, M.B.B.S., from Northern Beaches Hospital in Sydney, and colleagues developed a position statement on the diagnosis and management of acute leukemia and aggressive lymphomas in pregnancy, which pose a unique challenge as both maternal and fetal well-being must be considered.

The authors note that diagnosis of hematological malignancies can be challenging in pregnancy, but timely diagnosis is required, with either a bone marrow aspirate and trephine or lymph node biopsy, or both. Imaging modalities without ionizing radiation are safe in pregnancy, but effects of radiation should be considered. A multidisciplinary collaborative approach to performing imaging in pregnancy is recommended. Furthermore, a multidisciplinary approach to care is required. To avoid conflicting advice to patients, clear, consistent, multidisciplinary communication between teams is imperative. Unless contraindicated, patients should receive standard-of-care hematological management to optimize both relapse-free and overall survival. Consideration of oncological and pregnancy-based issues and their interactions is important. Key clinical considerations include the natural history of the underlying malignancy, parental wishes and expectations, and physiological changes in pregnancy that may impact pharmacokinetics. Access to nursing and midwifery specialists and comprehensive counseling relating to medication exposures during pregnancy and breastfeeding are recommended.

"In providing optimal care, close communication, shared decision-making, and maintaining focus on the goals of a successful pregnancy outcome and a complication-free survival are necessary," the authors write. "Evidence-based and empathic multidisciplinary care is crucial to achieve these aims."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-01-09 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords